CVS Health Corporation (CVS)
CVS Health tops second-quarter estimates, raises full-year profit outlook
CVS Health Corp (NYSE:CVS) reported second-quarter revenue and profit that beat Wall Street estimates on Wednesday, and raised its full-year adjusted earnings guidance, though cautious guidance pressured shares. Revenue rose 7.3% year-over-year to $106.1 billion, above analyst estimates of $100.11 billion.
Here's Why CVS Health (CVS) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CVS Health (CVS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for CVS Health (CVS) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CVS Health (CVS) Q2 Earnings and Revenues Beat Estimates
CVS Health (CVS) came out with quarterly earnings of $2.58 per share, beating the Zacks Consensus Estimate of $1.87 per share. This compares to earnings of $1.81 per share a year ago.
CVS blows past estimates, hikes guidance as insurance unit continues to improve
CVS Health blew past second-quarter earnings and revenue estimates and raised its 2026 guidance, as its insurance unit Aetna shows signs of recovery. All three of the healthcare giant's business segments – insurance, pharmacy and health services —surpassed Wall Street's revenue expectations.
CVS's Turnaround Faces Its Next Test
CVS Health reports earnings Wednesday, with analysts expecting another solid quarter and looking for potential guidance upside from its Aetna insurance and Caremark pharmacy-benefit businesses.
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CVS Health's Q2 Earnings on Deck: How Should You Play the Stock?
CVS heads into Q2 earnings with estimates pointing to revenue and EPS growth as Aetna initiatives and key business segments support results.
Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Stay Ahead of the Game With CVS Health (CVS) Q2 Earnings: Wall Street's Insights on Key Metrics
Beyond analysts' top-and-bottom-line estimates for CVS Health (CVS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.
CVS Health (CVS) Earnings Expected to Grow: Should You Buy?
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CVS Health (CVS) Laps the Stock Market: Here's Why
CVS Health (CVS) closed the most recent trading day at $109.34, moving +2.12% from the previous trading session.
